glp-1 agonist. PDB-101: Molecule of the Month: Receptor Agonists How GLP-1 Receptor Agonists Evolved
Description
367 A study involving 12-week-old ovariectomized mice revealed that administering liraglutide for 4 weeks effectively prevented the loss of trabecular bone
Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation
However, Novo Nordisk is expected to emerge as the leading company, having a large portfolio of GLP1 drugs, and is expected to capture 55 per cent of the market share in 2029.
So I called up a co-author of the study, the Washington University physician-scientist Ziyad Al-Aly
